Financial Market Analysis & Investment Research Partly open
Thermo Fisher (TMO) – Forecast met, new forecast, and +165.4%
Thermo Fisher Scientific (TMO), a "picks-and-shovels" supplier for biotech and pharma. The June material revisits the author's earlier view from January, checks the stock in gold and in the American currency, and examines revenue, margins and how profit is spent on dividends and repurchases. The key question: is heavy capital return enough to hold the stock.
Already subscribed to «Financial Market Analysis & Investment Research»? Then sign in to read it. Sign in
Full version
The closed part follows
The full material is available with the «Financial Market Analysis & Investment Research 42$» subscription, or as a single view for $10.
- the full set of indicators and market factors;
- an interpretation of the current picture;
- conclusions and the signals that follow.
Sign in or register — then you can buy this material separately.